Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the only company to have ...
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after ...
EMERYVILLE, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc. (NASDAQ: VANI), an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
Blindness affects millions of people worldwide and severely limits their independence, daily functioning, and overall quality of life. In Spain, the prevalence of blindness is estimated at 0.17% , ...
ALAMEDA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results